Amniotic Membrane Market Forecast to 2030

The amniotic membrane (AM), the innermost layer of the placenta, is made up of cells and tissues that act as a mechanism for soft tissue regeneration after a wound. The amniotic membrane contains biologically active cells that secrete growth factors and cytokines with anti-inflammatory, anti-immunogenic, and anti-fibrotic qualities. These cells are found in both the epithelial and stromal layers. The market is also expanding for amniotic membrane eye treatments. The amniotic membrane market study states that recent growth in tissue-based products is attributable to higher transplant rates brought on by more awareness.

The industry is expanding because of more donations brought about by increased awareness. Amniotic membranes are frequently used for a variety of conditions, including pressure and venous leg ulcers, corneal ulcers, limbal stem cell deficiency, pterygium excisions, surgical wounds, and regenerative medicine. Without a doubt, the industry will grow swiftly and consistently. The development of amniotic membrane in the field of amniotic membrane ophthalmology is also being researched and studied, as is the amniotic membrane transplantation technique that will be used in the future.

Segment Overview

The market for amniotic membranes is divided into two product categories: cryopreserved and dehydrated amniotic membrane respectively. The amniotic membrane market is segmented based on its application, which includes surgical wounds, ophthalmology, and others.

Regional Analysis

The amniotic membrane market has been divided into four regions: Asia-Pacific, North America, Europe and other countries. North America having the major share of the market and is expected to continue to do so in the coming years due to the presence of leading industry players and well-established healthcare facilities. Meanwhile, Europe is projected to have the highest growth rate and largest market share by the end of the forecast period, thanks to public funding for the healthcare system and the implementation of universal healthcare systems in several countries. The market for amniotic membrane is also expected to grow in other parts of the world. The target end-users for this market include hospitals, ambulatory surgical centers, specialty clinics, and academic and research institutions.

Major Players

Amniotic Membrane market leading companies consist of Alliqua BioMedical Inc.; Human Regenerative Technologies, LLC; Applied Biologics, LLC; DermaSciences; Amniox Medical Inc.; Amnio Technology, LLC; Skye Biologics, Inc.; MiMedx Group Inc.; and Organogensis, Inc.

COVID 19 Impacts

The market suffered from the COVID-19 pandemic. The limited capacities and resources (such as patient care specialists and hospital beds) were being reserved or redistributed toward COVID-19 patient care; therefore, elective surgeries were being refused (cancelled/postponed). Curfews and lockdowns have also been enforced in numerous countries to combat the escalating COVID-19 cases. Patients were unable to visit clinics, hospitals, or OPDs as a result of these lockdowns. This temporary ban on non-emergent healthcare services constrained the expansion of the amniotic membranes market. However, it is projected that the need for amniotic products would rise over the future years.

Product Code: MRFR/LS/4190-CR

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION 15
2.2 SCOPE OF THE STUDY 15
2.3 ASSUMPTIONS & LIMITATIONS 15
- 2.3.1 ASSUMPTIONS 15
- 2.3.2 LIMITATIONS 15
2.4 MARKET STRUCTURE 16

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

4.1 INTRODUCTION 26
4.2 DRIVERS 27
- 4.2.1 RISING AMNIOTIC MEMBRANE TRANSPLANTATIONS 27
- 4.2.2 RAPID GROWTH IN THE GERIATRIC POPULATION 27
- 4.2.3 INCREASING RESEARCH ACTIVITIES 28
4.3 RESTRAINTS 28
- 4.3.1 RISING HEALTHCARE COST 28
- 4.3.2 STRINGENT REGULATORY POLICIES 28
4.4 OPPORTUNITIES 29
- 4.4.1 ENTERING DEVELOPING ECONOMIES 29
- 4.4.2 INCREASING AWARENESS ABOUT THE ADVANTAGES OF AMNIOTIC MEMBRANE TRANSPLANT 29

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS 30
- 5.1.1 R&D 30
- 5.1.2 MANUFACTURING 30
- 5.1.3 DISTRIBUTION & SALES 30
- 5.1.4 POST-SALES MONITORING 31
5.2 PORTER'S FIVE FORCES ANALYSIS 31
- 5.2.1 BARGAINING POWER OF SUPPLIERS 31
- 5.2.2 BARGAINING POWER OF BUYERS 32
- 5.2.3 THREAT OF NEW ENTRANTS 32
- 5.2.4 THREAT OF SUBSTITUTES 32
- 5.2.5 INTENSE RIVALRY 32
5.3 INVESTMENT OPPORTUNITIES 33
5.4 PRICING ANALYSIS 33

6 AMNIOTIC MEMBRANE MARKET, BY TYPE

6.1 OVERVIEW 34
6.2 CRYOPRESERVATION AMNIOTIC MEMBRANE 35
6.3 LYOPHILIZED AMNIOTIC MEMBRANE 36

7 AMNIOTIC MEMBRANE MARKET, BY APPLICATION

7.1 OVERVIEW 37
7.2 SURGICAL WOUNDS 38
7.3 OPHTHALMOLOGY 39
7.4 STEM CELL BIOLOGY 39
7.5 REGENERATIVE MEDICINE 40
7.6 PRENATAL DIAGNOSIS 41
7.7 OTHERS 41

8 AMNIOTIC MEMBRANE MARKET, BY END USER

8.1 OVERVIEW 42
8.2 HOSPITAL & CLINICS 43
8.3 AMBULATORY SURGICAL CENTERS 44
8.4 RESEARCH CENTERS AND LABORATORY 45
8.5 OTHERS 45